Annual D&A
Summary
- Current Value
- As of today, DXCM annual D&A is $217.70M, up +17.04% on
- Historical Performance
- DXCM annual D&A is up +113.64% over the past 3 years, and up +347.02% over the past 5 years
- All-Time High Comparison
- DXCM annual D&A is currently at its all-time high
- 3-Year Low Comparison
- DXCM annual D&A is +39.64% above its 3-year low of $155.90M reached on an earlier date
- Sector Comparison
- DXCM annual D&A is higher than 92.23% of companies in Healthcare sector
Depreciation & Amortization Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual D&A | $217.70M | +17.0% | +113.6% | +347.0% | +9074.0% | |
| Quarterly D&A | $63.60M | +15.0% | +62.2% | +245.7% | +10000.0% | |
| TTM D&A | $244.40M | +15.1% | +61.2% | +300.7% | +10000.0% | |
| Price | $70.25 | -11.3% | -35.2% | -20.2% | +1725.9% | |
| Annual SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Annual Total Expenses | $3.43B | +13.5% | +57.3% | +157.4% | +4445.4% | |
| Annual Operating Expenses | $1.84B | +8.7% | +29.9% | +132.9% | +3614.0% | |
| Annual Revenue | $4.03B | +11.3% | +64.7% | +173.2% | +10000.0% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $217.70M | at high | |
| 5Y | $217.70M | at high | |
| All | $217.70M | at high |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $155.90M | N/A | +39.6% |
| 5Y | $67.10M | N/A | +224.4% |
| All | $353.50K | >+9999.0% |
Depreciation & Amortization History
FAQ
What is the current annual D&A of DXCM?
As of today, DXCM annual D&A is $217.70M
What is 1-year change in DXCM annual D&A?
DXCM annual D&A is up +17.04% year-over-year
What is 3-year change in DXCM annual D&A?
DXCM annual D&A is up +113.64% over the past 3 years
How far is DXCM annual D&A from its all-time high?
DXCM annual D&A is currently at its all-time high
How does DXCM annual D&A rank versus sector peers?
DXCM annual D&A is higher than 92.23% of companies in Healthcare sector
When is DXCM next annual earnings release?
The next annual earnings release for DXCM is on
Quarterly D&A
Summary
- Current Value
- As of today, DXCM quarterly D&A is $63.60M, up +0.95% on
- Historical Performance
- DXCM quarterly D&A is up +15.01% year-over-year, and up +62.24% over the past 3 years
- All-Time High Comparison
- DXCM quarterly D&A is currently at its all-time high
- 3-Year Low Comparison
- DXCM quarterly D&A is +75.21% above its 3-year low of $36.30M reached on an earlier date
- Sector Comparison
- DXCM quarterly D&A is higher than 91.72% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly D&A | $63.60M | +0.9% | +15.0% | +62.2% | +245.7% | |
| Annual D&A | $217.70M | – | +17.0% | +113.6% | +347.0% | |
| TTM D&A | $244.40M | +3.5% | +15.1% | +61.2% | +300.7% | |
| Price | $70.25 | +6.1% | -11.3% | -35.2% | -20.2% | |
| Quarterly SG&A | $331.40M | +1.0% | +8.2% | +41.3% | +109.0% | |
| Quarterly Total Expenses | $925.50M | -5.3% | +7.7% | +38.5% | +115.9% | |
| Quarterly Operating Expenses | $504.90M | +6.0% | +14.3% | +64.2% | +105.0% | |
| Quarterly Revenue | $1.21B | +4.5% | +21.6% | +57.1% | +141.4% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $63.60M | at high | |
| 3Y | $63.60M | at high | |
| 5Y | $63.60M | at high | |
| All | $63.60M | at high |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $57.80M | N/A | +10.0% |
| 3Y | $36.30M | N/A | +75.2% |
| 5Y | $20.40M | N/A | +211.8% |
| All | $147.60K | >+9999.0% |
Quarterly D&A History
FAQ
What is the current quarterly D&A of DXCM?
As of today, DXCM quarterly D&A is $63.60M
What is DXCM quarterly D&A most recent change?
DXCM quarterly D&A was up +0.95% on September 30, 2025
What is 1-year change in DXCM quarterly D&A?
DXCM quarterly D&A is up +15.01% year-over-year
How far is DXCM quarterly D&A from its all-time high?
DXCM quarterly D&A is currently at its all-time high
How does DXCM quarterly D&A rank versus sector peers?
DXCM quarterly D&A is higher than 91.72% of companies in Healthcare sector
When is DXCM next earnings release?
The next earnings release for DXCM is on
TTM D&A
Summary
- Current Value
- As of today, DXCM TTM D&A is $244.40M, up +3.52% on
- Historical Performance
- DXCM TTM D&A is up +15.07% year-over-year, and up +61.21% over the past 3 years
- All-Time High Comparison
- DXCM TTM D&A is currently at its all-time high
- 3-Year Low Comparison
- DXCM TTM D&A is +56.77% above its 3-year low of $155.90M reached on an earlier date
- Sector Comparison
- DXCM TTM D&A is higher than 91.92% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM D&A | $244.40M | +3.5% | +15.1% | +61.2% | +300.7% | |
| Annual D&A | $217.70M | – | +17.0% | +113.6% | +347.0% | |
| Quarterly D&A | $63.60M | +0.9% | +15.0% | +62.2% | +245.7% | |
| Price | $70.25 | +6.1% | -11.3% | -35.2% | -20.2% | |
| TTM SG&A | $7.35B | +477.9% | +480.0% | +683.5% | +1180.9% | |
| TTM Revenue | $4.52B | +5.0% | +14.2% | +61.7% | +148.0% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $244.40M | at high | |
| 3Y | $244.40M | at high | |
| 5Y | $244.40M | at high | |
| All | $244.40M | at high |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $217.70M | N/A | +12.3% |
| 3Y | $155.90M | N/A | +56.8% |
| 5Y | $67.10M | N/A | +264.2% |
| All | $147.60K | >+9999.0% |
TTM D&A History
FAQ
What is the current TTM D&A of DXCM?
As of today, DXCM TTM D&A is $244.40M
What is DXCM TTM D&A most recent change?
DXCM TTM D&A was up +3.52% on September 30, 2025
What is 1-year change in DXCM TTM D&A?
DXCM TTM D&A is up +15.07% year-over-year
How far is DXCM TTM D&A from its all-time high?
DXCM TTM D&A is currently at its all-time high
How does DXCM TTM D&A rank versus sector peers?
DXCM TTM D&A is higher than 91.92% of companies in Healthcare sector
When is DXCM next earnings release?
The next earnings release for DXCM is on
Data Sources & References
- DXCM Official Website www.dexcom.com/global
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1093557/000109355725000280/0001093557-25-000280-index.htm
- DXCM Profile on Yahoo Finance finance.yahoo.com/quote/DXCM
- DXCM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dxcm
